Singapore markets close in 5 hours 37 minutes

Universe Pharmaceuticals INC (UPC)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
0.5874-0.0029 (-0.49%)
At close: 11:24AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 13.17M
Enterprise value -1.76M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)0.32
Price/book (mrq)0.28
Enterprise value/revenue -0.04
Enterprise value/EBITDA 0.24

Trading information

Stock price history

Beta (5Y monthly) 1.83
52-week change 3-52.81%
S&P500 52-week change 3-10.89%
52-week high 32.0800
52-week low 30.5000
50-day moving average 30.6818
200-day moving average 30.8915

Share statistics

Avg vol (3-month) 3237.93k
Avg vol (10-day) 33.75k
Shares outstanding 521.75M
Implied shares outstanding 6N/A
Float 89.27M
% held by insiders 157.38%
% held by institutions 10.34%
Shares short (14 Mar 2023) 437.61k
Short ratio (14 Mar 2023) 42.12
Short % of float (14 Mar 2023) 40.41%
Short % of shares outstanding (14 Mar 2023) 40.17%
Shares short (prior month 14 Feb 2023) 431.53k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 29 Sept 2022
Most-recent quarter (mrq)29 Sept 2022


Profit margin -21.76%
Operating margin (ttm)-18.53%

Management effectiveness

Return on assets (ttm)-7.17%
Return on equity (ttm)-16.58%

Income statement

Revenue (ttm)40.14M
Revenue per share (ttm)1.85
Quarterly revenue growth (yoy)-32.70%
Gross profit (ttm)21.89M
Net income avi to common (ttm)-8.74M
Diluted EPS (ttm)-0.3800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)18.86M
Total cash per share (mrq)0.87
Total debt (mrq)3.94M
Total debt/equity (mrq)8.48
Current ratio (mrq)3.17
Book value per share (mrq)2.13

Cash flow statement

Operating cash flow (ttm)-1.31M
Levered free cash flow (ttm)3.98M